Keywords: kinetek, starts, phase, kp-102, pharmaceuticals, begun, trial

Kinetek starts Phase I with KP-102

Article | 22 December 1998

Print This

Kinetek Pharmaceuticals has begun a Phase I trial of its antidiabetic,KP-102, one month after filing an Investigational New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in